Conference Reports for NATAP

Conference on Retroviruses and Opportunistic Infections (CROI) Boston, Massachusetts March 4-7, 2018 Back

[Bictegravir] Integrase Inhibitor Resistance Selections Initiated with Drug Resistant HIV-1       Reported by Jules Levin CROI 2018 March 4-7 Boston MA   K Andreatta*, S Chang, R Martin, M Willkom, and KL White Gilead Sciences, Inc., Foster City, CA   WEBCAST Themed Discussion: http://www.croiwebcasts.org/console/player/37223?mediaType=slideVideo&&crd_fl=1&ssmsrq=1521978089468&ctms=5000&csmsrq=928